The transcriptional repressor Fli1 inhibits proteostasis during nutrient stress to limit NK cell persistence in solid
Jeong Hyun Ji1, Wesley R Armstrong2, Joey H Li2
1Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, USA.
Abstract:
Tumor-infiltrating natural killer (NK) cells display reduced persistence and effector functions. Here, we examined the mechanisms underlying NK cell dysfunction in cancer. Gene expression analyses of matched tumor-infiltrating and tumor-adjacent human NK cells revealed that regulators of proteostasis were associated with worse survival outcomes. In mice, NK cells accumulated intracellular protein aggregates within 24 h of tumor infiltration. Nutrient stress in the tumor microenvironment (TME) triggered proteostasis imbalance in primary human NK cells, decreasing translation of cytokine receptors and inhibiting NK cell activation. SCENIC regulon and multiomic analyses identified FLI1 as a transcriptional repressor of the unfolded protein response (UPR) in NK cells. FLI1 induction following IL-15 signaling suppressed pro-survival UPR gene expression, limiting human NK cell proteostasis and intra-tumoral persistence. Fli1 deletion reduced protein aggregates and enhanced NK cell-mediated tumor control in vivo. Thus, the TME metabolome induces NK cell dysfunction through proteostasis imbalance, and FLI1 targeting may enhance NK cell anti-tumor function.
Insights
Tumor-infiltrating natural killer (NK) cells become dysfunctional due to protein buildup in the tumor microenvironment. Targeting FLI1 may restore NK cell anti-tumor activity.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Tumor-infiltrating natural killer (NK) cells exhibit impaired persistence and effector functions in the tumor microenvironment (TME).
- Understanding the mechanisms of NK cell dysfunction is crucial for improving cancer immunotherapy.
Purpose of the Study:
- To investigate the molecular mechanisms driving NK cell dysfunction within the TME.
- To identify potential therapeutic targets for enhancing NK cell anti-tumor activity.
Main Methods:
- Gene expression analysis of human NK cells from tumors and adjacent tissues.
- In vivo studies using mouse models to assess NK cell behavior and tumor control.
- Multiomic analyses, including SCENIC regulon analysis, to identify key regulatory factors.
- Assessment of proteostasis, protein aggregation, and unfolded protein response (UPR) in NK cells.
Main Results:
- Regulators of proteostasis correlated with poorer survival outcomes in cancer patients.
- NK cells infiltrating tumors rapidly accumulated intracellular protein aggregates.
- Nutrient stress in the TME induced proteostasis imbalance, impairing NK cell activation and cytokine receptor translation.
- FLI1 was identified as a repressor of the UPR, and its induction suppressed pro-survival UPR genes, limiting NK cell proteostasis and persistence.
- Deletion of Fli1 in mice reduced protein aggregates and improved NK cell-mediated tumor control.
Conclusions:
- The TME metabolome contributes to NK cell dysfunction via proteostasis imbalance.
- FLI1 plays a critical role in suppressing NK cell proteostasis and intra-tumoral persistence.
- Targeting FLI1 presents a potential strategy to enhance NK cell anti-tumor functions in cancer therapy.
More Related Videos
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Regulation of Nuclear Protein Sorting
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Abnormal Proliferation
Regulation of the Unfolded Protein Response
Stringent Response in E. coli
